USA Kutumiza Kwawo Kumudzi, Canada Kutumiza Kwawo, Kunyumba kwa ku Ulaya

Apatinib (811803-05-1)

mlingo:
5.00 kuchokera 5 kutengera 1 kasitomala mlingo
SKU: 811803-05-1. Category:

AASraw ili ndi kaphatikizidwe ndi kapangidwe kake kuchokera ku gramu kupita ku Apatinib (CAS 811803-05-1), pansi pa lamulo la CGMP ndi dongosolo loyendetsa khalidwe labwino.

Apatinib, kachilombo kakang'ono kakang'ono kotchedwa tyrosine kinase inhibitor kamene kamateteza mitsempha yotchedwa growth reception-receptor-2, inavomerezedwa kuti ikhale ndi mchere wa adenocarcinoma ku China mu Oct 2014. Ili ndilo lipoti loyambirira pa ntchito yake kwa khansa yapamwamba kwambiri ngati mtundu wa mankhwala a mzere wachitatu kuti ufike lero.

Pulogalamu ya AASRAW PDF Icon

Mafotokozedwe Akatundu

Video ya Apatinib


Apatinib Basic Characters

Name: Apatinib
CAS: 811803-05-1
Makhalidwe a Maselo: C24H23N5O
Kulemera kwa maselo: 397.47232
Melt Point: 111-114 ° C
Kusungirako nyengo: -20 ° C
mtundu; Yellow Yellow to Yellow Solid


Apatinib (811803-05-1) ntchito mu steroid cycle

Mayina

Apatinib (CAS 811803-05-1), yotchedwanso YN968D1, Mesylate.

Ntchito ya Apatinib

Odwala khansa ankapatsidwa mitundu yosiyanasiyana ya Apatinib tsiku tsiku la 28. Apatinib ankalekerera pa mlingo womwe unali pansi pa 750 mg / tsiku, 3 ya 3 mlingo wochepetsa chiopsezo unanenedwa pa 1000 mg / tsiku ndipo mlingo wokhala ndi chiwerengero cholekerera umatsimikiziridwa kukhala be850 mg / tsiku.

Chenjezo pa Apatinib

Muyenera kudziwa zotsatira zake pamene mutenga Apatinib. Zomwe zimachititsa kuti apatinib akhale ndi matenda oopsa komanso matenda a miyendo; Komabe, poizoni wa apatinib inali yolamulirika ndi yolekerera.

Maumboni ena

Rivoceranib (Apatinib, YN968D1) ndi wolemba mankhwala osokoneza bongo omwe amapezeka kunja kwa China ndi LSK BioPharma, pofuna kuchiza matenda opatsirana kwambiri monga khansa yapakhungu kapena yamatenda, kansa yofiira, ndi hepatocellular carcinoma. YN968D1 inali yoyamba yopangidwa ndi yovomerezedwa ndi Advenchen Laboratories ku Southern California. Apatinib pakali pano amagulitsidwa ku China chifukwa cha khansa yapakhungu yowonjezera ndi chigawo cha Chinese-territory license holder, Jiangsu Hengrui MedicineCo., Ltd pansi pa dzina la Aitan®. LSK BioPharma ali ndi ufulu wadziko lonse (kuphatikizapo China) ndipo waphatikizana ndi chitukuko ndi malonda a rivoceranibin South Korea.

Rivoceranib ndi njira yowonongeka yothamanga kwambiri yotenga factor factor receptor-2 (yotchedwa VEGFR2) yomwe imayanjanitsa njira yoyamba ya tumor mediatedangiogenesis. Zakhala zikuyesedwa ndi anthu oposa 1,000 padziko lonse lapansi ndipo zakhala zikuwoneka bwino m'matenda ambiri kuphatikizapo khansa ya m'mimba, khansara yofiira, hepatocellular carcinoma, kansa yaing'ono ya m'mapapo ya khansa, khansara yowopsa, khatekasi, mesothelioma, ndi zotupa za neuroendocrine. Zasonyezeranso kuti zingathe kusintha bwino zotsatira zake kuphatikizapo chemotherapeutics ndi immunotherapy, komanso mankhwala othandizira.


Momwe mungagulire Apatinib ku AASRAW

1.Kutiwuza ife ndi imelo yathu kafukufuku, kapena skype pa intanetiwoimira makasitomala (CSR).
2.Zotipatseni ife afunsidwa zambiri ndi adiresi yanu.
3.Our CSR idzakupatsani inu ndondomeko, nthawi yobwezera, nambala yotsatira, njira yobweretsera ndi tsiku lofika kufika (ETA).
4.Payment yachitidwa ndipo katunduyo adzatumizidwa mu maola a 12 (Kukonzekera mkati mwa 10kg).
5.Goods inalandira ndi kupereka ndemanga.


=

COA

HNMR

Maphikidwe

Mafotokozedwe ndi zolemba zamagulu